Ekinci, D <br/><br/>
The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.  [electronic resource] 

 -  Journal of B.U.ON. : official journal of the Balkan Union of Oncology   
 - 245-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1107-0625 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Metronomic<br/>Adult<br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bevacizumab<br/>Biomarkers, Tumor--blood<br/>Camptothecin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasms--blood<br/>Time Factors<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--blood